Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Mapstone

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
Journal of Clinical and Experimental Neuropsychology|August 17, 2010
Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methodsRobert M Chapman, Mark Mapstone, John W McCrary, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisTom Paterson, Jennifer Rohrs, Timothy J Hohman, et al.
The Open Geriatric Medicine Journal|August 19, 2010
Cognitive Dimensions in Alzheimer's Disease, Mild Cognitive Impairment, and Normal Elderly: Developing a Common MetricRobert M Chapman, Mark Mapstone, John W McCrary, et al.
Journal of Clinical and Experimental Neuropsychology|April 2, 2010
Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analysesRobert M Chapman, Mark Mapstone, Anton P Porsteinsson, et al.
Journal of Alzheimer'S Disease : JAD|August 14, 2012
C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's diseaseRobert M Chapman, Anton P Porsteinsson, Margaret N Gardner, et al.
Current Alzheimer Research|August 3, 2013
The impact of AD drug treatments on event-related potentials as markers of disease conversionRobert M Chapman, Anton P Porsteinsson, Margaret N Gardner, et al.
Journal of Neurovirology|August 10, 2017
Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individualsYuchuan Zhuang, Xing Qiu, Lu Wang, et al.
Applied Neuropsychology. Adult|March 28, 2026
A pilot study of neuropsychological testing in a civilian traumatic brain injury clinic: Neurocognitive profiles, temporal trends and cognitive screeningClaire Joyner, Amanda S Fang, Maria Paulino, et al.
Oncotarget|October 6, 2017
Metabolomic biomarkers of pancreatic cancer: a meta-analysis studyKhyati Y Mehta, Hung-Jen Wu, Smrithi S Menon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 19, 2014
Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control studyMassimo S Fiandaca, Dimitrios Kapogiannis, Mark Mapstone, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
Journal of Clinical and Experimental Neuropsychology|August 17, 2010
Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methodsRobert M Chapman, Mark Mapstone, John W McCrary, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisTom Paterson, Jennifer Rohrs, Timothy J Hohman, et al.
The Open Geriatric Medicine Journal|August 19, 2010
Cognitive Dimensions in Alzheimer's Disease, Mild Cognitive Impairment, and Normal Elderly: Developing a Common MetricRobert M Chapman, Mark Mapstone, John W McCrary, et al.
Journal of Clinical and Experimental Neuropsychology|April 2, 2010
Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analysesRobert M Chapman, Mark Mapstone, Anton P Porsteinsson, et al.
Journal of Alzheimer'S Disease : JAD|August 14, 2012
C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's diseaseRobert M Chapman, Anton P Porsteinsson, Margaret N Gardner, et al.
Current Alzheimer Research|August 3, 2013
The impact of AD drug treatments on event-related potentials as markers of disease conversionRobert M Chapman, Anton P Porsteinsson, Margaret N Gardner, et al.
Journal of Neurovirology|August 10, 2017
Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individualsYuchuan Zhuang, Xing Qiu, Lu Wang, et al.
Applied Neuropsychology. Adult|March 28, 2026
A pilot study of neuropsychological testing in a civilian traumatic brain injury clinic: Neurocognitive profiles, temporal trends and cognitive screeningClaire Joyner, Amanda S Fang, Maria Paulino, et al.
Oncotarget|October 6, 2017
Metabolomic biomarkers of pancreatic cancer: a meta-analysis studyKhyati Y Mehta, Hung-Jen Wu, Smrithi S Menon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 19, 2014
Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control studyMassimo S Fiandaca, Dimitrios Kapogiannis, Mark Mapstone, et al.
Pageof 15